{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:26:55Z","timestamp":1793698015307,"version":"4.5.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"DOI":"10.1007\/s11096-026-02201-4","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:19:12Z","timestamp":1785320352000},"page":"2226-2236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Global burden and future trends of type 2 diabetes mellitus-associated chronic kidney disease: analysis of the Global Burden of Disease Study 2021"],"prefix":"10.1007","volume":"48","author":[{"given":"Naitao","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhujin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaolian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"2201_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"Collaborators GBDD","year":"2023","unstructured":"Collaborators GBDD. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203\u201334.","journal-title":"Lancet"},{"key":"2201_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88\u201398.","journal-title":"Nat Rev Endocrinol"},{"key":"2201_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"Collaboration GBDCKD","year":"2020","unstructured":"Collaboration GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709\u201333.","journal-title":"Lancet"},{"key":"2201_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-024-02288-1","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xu Y, Shan H, et al. Health state utility values of type 2 diabetes mellitus and related complications: a systematic review and meta-regression. Health Qual Life Outcomes. 2024;22:74.","journal-title":"Health Qual Life Outcomes"},{"key":"2201_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-015-0204-5","volume":"14","author":"L Cea Soriano","year":"2015","unstructured":"Cea Soriano L, Johansson S, Stefansson B, et al. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors. Cardiovasc Diabetol. 2015;14:38.","journal-title":"Cardiovasc Diabetol"},{"key":"2201_CR6","doi-asserted-by":"publisher","first-page":"10222","DOI":"10.3390\/ijms251810222","volume":"25","author":"E Mlynarska","year":"2024","unstructured":"Mlynarska E, Bulawska D, Czarnik W, et al. Novel insights into diabetic kidney disease. Int J Mol Sci. 2024;25:10222.","journal-title":"Int J Mol Sci"},{"key":"2201_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2337\/diaspect.28.3.214","volume":"28","author":"JJ Neumiller","year":"2015","unstructured":"Neumiller JJ, Hirsch IB. Management of hyperglycemia in diabetic kidney disease. Diabetes Spectr. 2015;28:214\u20139.","journal-title":"Diabetes Spectr"},{"key":"2201_CR8","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/00325481.2021.2009726","volume":"134","author":"JH Shubrook","year":"2022","unstructured":"Shubrook JH, Neumiller JJ, Wright E. Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations. Postgrad Med. 2022;134:376\u201387.","journal-title":"Postgrad Med"},{"key":"2201_CR9","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stefansson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383:1436\u201346.","journal-title":"N Engl J Med"},{"key":"2201_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"WG Herrington","year":"2023","unstructured":"The E-KCG, Herrington WG, Staplin N, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388:117\u201327.","journal-title":"N Engl J Med"},{"key":"2201_CR11","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383:2219\u201329.","journal-title":"N Engl J Med"},{"key":"2201_CR12","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","volume":"385","author":"B Pitt","year":"2021","unstructured":"Pitt B, Filippatos G, Agarwal R, et al. Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med. 2021;385:2252\u201363.","journal-title":"N Engl J Med"},{"key":"2201_CR13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","volume":"102","author":"Kidney Disease: Improving Global Outcomes Diabetes Work G","year":"2022","unstructured":"Kidney Disease: Improving Global Outcomes Diabetes Work G. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102:S1\u2013127.","journal-title":"Kidney Int"},{"key":"2201_CR14","doi-asserted-by":"publisher","first-page":"S246","DOI":"10.2337\/dc26-S011","volume":"49","author":"American Diabetes Association Professional Practice Committee for D. 11","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for D. 11. Chronic kidney disease and risk management: standards of care in diabetes-2026. Diabetes Care. 2026;49:S246\u201360.","journal-title":"Diabetes Care"},{"key":"2201_CR15","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.mayocp.2022.05.003","volume":"97","author":"R Alicic","year":"2022","unstructured":"Alicic R, Nicholas SB. Diabetic kidney disease back in focus: management field guide for health care professionals in the 21st century. Mayo Clin Proc. 2022;97:1904\u201319.","journal-title":"Mayo Clin Proc"},{"key":"2201_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-21851-z","volume":"25","author":"L Deng","year":"1990","unstructured":"Deng L, Guo S, Liu Y, et al. Global, regional, and national burden of chronic kidney disease and its underlying etiologies from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021. BMC Public Health. 1990;25:636.","journal-title":"BMC Public Health"},{"key":"2201_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s41182-025-00703-x","volume":"53","author":"J Chen","year":"1990","unstructured":"Chen J, Deng M, Zheng R, et al. Global, regional, and national trends in chronic kidney disease burden (1990-2021): a systematic analysis of the global burden of disease in 2021. Trop Med Health. 1990;53:26.","journal-title":"Trop Med Health"},{"key":"2201_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/dom.15349","volume":"26","author":"W Liu","year":"2024","unstructured":"Liu W, Zhang D, Wang R, et al. Global trends in the burden of chronic kidney disease attributable to type 2 diabetes: an age-period-cohort analysis. Diabetes Obes Metab. 2024;26:602\u201310.","journal-title":"Diabetes Obes Metab"},{"key":"2201_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70084","volume":"17","author":"Y Wang","year":"1990","unstructured":"Wang Y, Gu S, Xie Z, et al. Trends and disparities in the burden of chronic kidney disease due to Type 2 Diabetes in China from 1990 to 2021: a population-based study. J Diabetes. 1990;17:e70084.","journal-title":"J Diabetes"},{"key":"2201_CR20","doi-asserted-by":"publisher","first-page":"848","DOI":"10.4093\/dmj.2024.0593","volume":"49","author":"Y Cao","year":"1992","unstructured":"Cao Y, Chen H, Liu H, et al. Global, regional, and national temporal trends in incidence for Type 2 Diabetes Mellitus related chronic kidney disease from 1992 to 2021. Diabetes Metab J. 1992;49:848\u201361.","journal-title":"Diabetes Metab J"},{"key":"2201_CR21","doi-asserted-by":"publisher","first-page":"1501175","DOI":"10.3389\/fmed.2024.1501175","volume":"11","author":"J Guo","year":"2024","unstructured":"Guo J, Liu Z, Wang P, et al. Global, regional, and national burden inequality of chronic kidney disease, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Front Med (Lausanne). 2024;11:1501175.","journal-title":"Front Med (Lausanne)"},{"key":"2201_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2512400","volume":"47","author":"Z Rao","year":"2021","unstructured":"Rao Z, Wang K, Zhou K, et al. Global burden and epidemic trends of chronic kidney disease attributable to high body mass index: insights from the Global Burden of Disease Study 2021. Ren Fail. 2021;47:2512400.","journal-title":"Ren Fail"},{"key":"2201_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1572610","volume":"12","author":"Y Hou","year":"2021","unstructured":"Hou Y, Qin L, Jin X, et al. Systematic analysis of the burden of chronic kidney disease due to type 2 diabetes attributable to dietary risks based on the global burden of disease study 2021. Front Nutr. 2021;12:1572610.","journal-title":"Front Nutr"},{"key":"2201_CR24","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s40620-023-01676-y","volume":"36","author":"F Pizzarelli","year":"2023","unstructured":"Pizzarelli F, Basile C, Aucella F, et al. Chronic kidney disease in the elderly and frail patient: perspectives with opinions and comments. J Nephrol. 2023;36:1565\u201370.","journal-title":"J Nephrol"},{"key":"2201_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.cger.2019.03.009","volume":"35","author":"F Musio","year":"2019","unstructured":"Musio F. Kidney disease and anemia in elderly patients. Clin Geriatr Med. 2019;35:327\u201337.","journal-title":"Clin Geriatr Med"},{"key":"2201_CR26","doi-asserted-by":"crossref","unstructured":"Francis A, Harhay MN, Ong ACM, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20:473\u2013485.","DOI":"10.1038\/s41581-024-00820-6"},{"key":"2201_CR27","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/jama.2017.4046","volume":"317","author":"AK Bello","year":"2017","unstructured":"Bello AK, Levin A, Tonelli M, et al. Assessment of global kidney health care status. JAMA. 2017;317:1864\u201381.","journal-title":"JAMA"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02201-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02201-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02201-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:39:02Z","timestamp":1793695142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02201-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2201"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02201-4","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"9 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study analyzed publicly available, de-identified data from the GBD 2021 study. Therefore, ethics committee or institutional review board approval was not required.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}